The trademark application MAGNERELAX was filed by Oak Pharma BV, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 26, 2021, and it was registered by office on August 3, 2021 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
A transfer of the trademark registration was recorded on May 17, 2022.